MYND Life Sciences(TSE:MYND)
CA$0.070.00 (0.00%)
TSE:MYND
MYND Life Sciences financials statements
CA$0.07
At close:0.00 (0.00%)
MYND Life Sciences (MYND) Income Statement
20 Followers
MYND Life Sciences Income Statement
Last quarter (Q3 2024), MYND Life Sciences's total revenue was C$43.27K. In Q3, MYND Life Sciences's net income was C$-379.27K. See MYND Life Sciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jan 24 | Jan 23 | Jan 22 | Oct 20 | Oct 19 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ -332.99K | C$ -59.83K | C$ -86.12K | C$ 0.00 | C$ 0.00 | |
| C$ 1.47M | C$ 3.00M | C$ 4.29M | C$ 56.47K | C$ 2.54K | |
| Depreciation and Amortization | C$ 20.99K | C$ 59.83K | C$ 86.12K | C$ 56.47K | C$ 2.54K |
| C$ -1.81M | C$ -2.97M | C$ -4.21M | C$ 0.00 | C$ 0.00 | |
| C$ -1.81M | C$ -3.06M | C$ -4.29M | C$ -56.47K | C$ -2.54K | |
| C$ 289.92K | C$ -693.80K | C$ -243.93K | C$ 0.00 | C$ 0.00 | |
| C$ -1.52M | C$ -3.70M | C$ -4.54M | C$ -56.47K | C$ -2.54K | |
| C$ -1.52M | C$ -3.57M | C$ -4.37M | C$ -56.47K | C$ -2.54K | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.03 | C$ -0.08 | C$ -0.10 | C$ -0.00 | C$ 0.00 |
| Diluted EPS | C$ -0.03 | C$ -0.08 | C$ -0.10 | C$ -0.00 | C$ 0.00 |
| Weighted Average Shares Outstanding | 47.27M | 46.68M | 44.96M | 28.23M | 1.71M |
| Weighted Average Shares Outstanding (Diluted) | 47.27M | 46.68M | 44.96M | 28.23M | 1.71M |
Currency in CAD
